Hedge Fund - OrbiMed Advisors
Prevail Therapeutics Inc. (PRVL)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2021 - Q1 (2021-03-31) | $0 | 0% | 0 | $23.03 |
| 2 | 2020 - Q4 (2020-12-31) | $318,884,000 | 2.79% | 13,822,463 | $12.67 |
| 3 | 2020 - Q3 (2020-09-30) | $140,713,000 | 1.76% | 13,822,463 | $13.42 |
| 4 | 2020 - Q2 (2020-06-30) | $205,955,000 | 2.89% | 13,822,463 | $15.40 |
| 5 | 2020 - Q1 (2020-03-31) | $168,496,000 | 2.83% | 13,822,463 | $15.91 |
| 6 | 2019 - Q4 (2019-12-31) | $218,810,000 | 3.12% | 13,822,463 | $12.76 |
| 7 | 2019 - Q3 (2019-09-30) | $169,740,000 | 3.22% | 13,822,463 | $11.33 |
| 8 | 2019 - Q2 (2019-06-30) | $182,457,000 | 2.82% | 13,822,463 | $14.57 |
The displayed share prices are average quarterly stock market prices.